Vitiligo: Causes, Symptoms, Treatments & Quality of Life Impact

What Is Vitiligo?

Vitiligo is a chronic autoimmune condition where the immune system attacks melanocytes (pigment-producing cells), causing white patches (depigmentation) of varying size and location on the skin. It affects all ages, ethnicities, and skin types; not contagious; not life-threatening.

Cause

Autoimmune destruction of melanocytes. Exact trigger unknown—likely genetic susceptibility + environmental triggers (stress, sunburn, chemical exposure, trauma). Associated with other autoimmune diseases (thyroid, type 1 diabetes, alopecia areata).

Symptoms

• Milky-white patches, often symmetrical, on face, neck, hands, forearms, feet, body folds.
• Patches may enlarge, spread, or remain stable; unpredictable course.
• Hair, eyebrows, eyelashes, beard may turn white/gray (poliosis) or thin.
• Mucous membranes (mouth, nose) may lose pigment.

Impact on Quality of Life

Not physically painful, but profound psychosocial impact: disfigurement distress, social anxiety, isolation, discrimination, staring, lowered self-esteem, clinical depression, anxiety. Darker skin tones experience greater contrast and stigma.

Treatments (Manage, Not Cure)

• Topical: Corticosteroids, calcineurin inhibitors (tacrolimus, pimecrolimus), JAK inhibitors (ruxolitinib cream—FDA approved 2022).
• Phototherapy: Narrowband UVB (gold standard), excimer laser, PUVA (UVA + psoralen).
• Systemic: Oral corticosteroids (short-term), immunosuppressants (methotrexate, cyclosporine) for rapid spreading.
• Surgical (Stable Disease): Autologous melanocyte transplant, suction blister grafting, punch grafting.
• Depigmentation (Extensive >50% BSA): Monobenzone to remove remaining pigment for uniform appearance.
• Camouflage: High-coverage makeup (Dermablend, Microskin), self-tanners.

Treatment aims to stop progression, restore pigment (repigmentation), or achieve even color—not a cure. Multidisciplinary care (dermatology, mental health) optimizes outcomes.